Government of Chile   Report issue

Government Phase 1 Phase 2 Phase 3
Founded: Santiago Chile (1980)

Organization Overview

First Clinical Trial
2002
NCT00243815
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Corporación de Fomento de la Producción, Chile | Ejército de Chile, Hospital Militar de Santiago | Ministry of Health, Chile | Municipalidad de Lo Barnechea, Chile | Servicio de Salud Metropolitano Oriente, Ministerio de Salud de Chile

Active Ingredients

Drugs in Phase 3 Trials (2)

ibuprofen (motrin) (1 trial)

inactivated SARS-Cov-2 vaccine (2 trials)

Drugs in Phase 2 Trials (2)

atorvastatin (lipitor) (1 trial)

bnt162b2 (1 trial)

Drugs in Phase 1 Trials (2)

bacille calmette-guerin (1 trial)

rbcg-n-hrsv (1 trial)

Drugs in Other Trials (2)

azathioprine (imuran) (1 trial)

prednisone (meticorten) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 2)

Infections (Phase 3)

Periodontitis (Phase 2)

Respiratory Syncytial Virus Infections (Phase 1)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 8